Gleneagles Hong Kong and HKUMed are advancing liver cancer care through collaboration and innovation under IHH Healthcare’s leadership.
.gif?sfvrsn=d878d56e_1 "Untitled design (4)")
The International Liver Cancer Conference 2026 in Hong Kong brought together leading clinicians, researchers and healthcare innovators to explore new pathways in liver cancer treatment and education. Among the highlights was the joint participation of Gleneagles Hospital Hong Kong and the University of Hong Kong’s Faculty of Medicine (HKUMed), underscoring the city’s growing role as a hub for advanced oncology care and clinical collaboration.
Professor Chak-sing Lau, Vice-President and Pro-Vice-Chancellor (Health) and Dean of Medicine at HKUMed, emphasised the importance of academic–clinical partnerships in driving progress against liver cancer. His leadership has been instrumental in fostering collaboration between HKUMed and Gleneagles Hong Kong, enabling the translation of research breakthroughs into real-world clinical practice.
Dr Kenneth Tsang, Regional CEO of IHH Healthcare North Asia and CEO of Gleneagles Hospital Hong Kong, highlighted how the hospital’s commitment to innovation and multidisciplinary care reflects IHH Healthcare’s Strategy 2030 vision to trailblaze the industry through clinical excellence, research and technology. Under his leadership, Gleneagles Hong Kong continues to pioneer new approaches to liver cancer management through precision diagnostics, minimally invasive techniques and physician training.
The conference also served as a platform for experts to discuss emerging technologies such as histotripsy, a non-invasive ultrasound-based therapy first introduced in Asia by Gleneagles Hong Kong, and its potential to transform liver cancer treatment. Through continued collaboration and education, the hospital aims to strengthen Hong Kong’s position as a centre of excellence for hepatobiliary care.
By connecting research, clinical practice and education, IHH Healthcare and Gleneagles Hong Kong are shaping the future of liver cancer care. Colleagues across our network can draw inspiration from this model of partnership-driven innovation to advance better care for patients everywhere.
Related Stories
Shaping the Future of Healthcare Beyond Hospital Walls
At the 49th IHF World Hospital Congress, IHH Healthcare North Asia shared how connected care networks, digital innovation and preventive health can reshape care delivery.
Gleneagles BGS Champions Spine Health and Recovery
Gleneagles BGS Hospital brought together patients, clinicians and spine health advocates to celebrate life after spinal surgery while raising awareness of early diagnosis and timely intervention.
Pantai KL Brings Cancer Care Closer to More Communities
Pantai Hospital Kuala Lumpur has strengthened its oncology services with the soft launch of the Pantai Oncology Daycare Centre in Cheras, bringing cancer treatment closer to patients and families.
Gleneagles JPMC Strengthens Regional Cardiac Collaboration
Gleneagles JPMC joined leading cardiac professionals at the 30th ASEAN Federation of Cardiology Congress, supporting knowledge exchange and regional collaboration to advance cardiovascular care across ASEAN.
Gleneagles Hong Kong Advances Healthier Ageing Through Innovation
Gleneagles Hospital Hong Kong shared clinical insights and industry perspectives at Ageing Well Hong Kong 2026, highlighting how innovation, prevention and collaboration can support healthier ageing and improved quality of life.
Behind Every Blood Test, a Step Forward in Care
When a doctor is waiting for a blood test result, what happens inside the laboratory matters. Each stage, from processing a sample to reviewing its findings, helps shape the next decision in a patient’s care.
